United Therapeutics Corporation (UTHR) stock news · P/E 19, rev $3.18B
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This UTHR news page leads with what United Therapeutics Corporation filed — not a scraped headline mill.
No cached 8-K sentence for UTHR yet. We will not pad this page with generic market recap.
Latest reported UTHR revenue for 2025-12-31 was $3.18B. Net income was $1.33B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 19.4.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the UTHR stock page; for the tape open the quote page.
UTHR stock news FAQ
What are UTHR's latest revenue and net income?
Latest cached United Therapeutics Corporation (UTHR) revenue for Dec 31, 2025 was $3.18B. Net income was $1.33B. Statements: https://lician.com/financials/uthr
How did UTHR revenue change from the prior cached period?
Cached United Therapeutics Corporation (UTHR) revenue was up 10.6% from $2.88B (Dec 31, 2024) to $3.18B (Dec 31, 2025). Statements: https://lician.com/financials/uthr
What is UTHR's P/E ratio?
United Therapeutics Corporation (UTHR) trailing P/E is 19.4 on the latest cached fundamentals snapshot.
What is UTHR's market cap?
United Therapeutics Corporation (UTHR) market cap is $23.41B on the latest cached fundamentals snapshot.
What kind of company is UTHR?
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is UTHR stock news listed?
Cached stock news for United Therapeutics Corporation (UTHR) is listed at https://lician.com/news/uthr. Filings: https://lician.com/sec/uthr
Not investment advice.